Literature DB >> 1161965

Tricyclic antidepressants and tryptophan in unipolar depression.

D M Shaw, D A Macsweeney, R Hewland, A L Johnson.   

Abstract

Depressed patients (unipolar) were given one of the following combinations in an attempt to test aspects of the 'amine hypothesis' and to find a preferential therapy: (1) clomipramine; (2) clomipramine and tryptophan; (3) desipramine and clomipramine, and (4) desipramine and tryptophan. Treatment (2) should have given optimal potentiation of 5-HT neurones and (3) and (4) should have acted similarly on both serotoninergic and adrenergic pathways. In no group was there any evidence of accelerated recovery, indicating that the process of conversion to normal mood may be more complex than suggested by most versions of the amine hypothesis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1161965     DOI: 10.1017/s0033291700056646

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  2 in total

1.  Preliminary randomized double-blind placebo-controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects.

Authors:  R D Levitan; J H Shen; R Jindal; H S Driver; S H Kennedy; C M Shapiro
Journal:  J Psychiatry Neurosci       Date:  2000-09       Impact factor: 6.186

Review 2.  Use of tryptophan in combination with other antidepressant treatments: a review.

Authors:  S N Young
Journal:  J Psychiatry Neurosci       Date:  1991-12       Impact factor: 6.186

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.